Company Filing History:
1 out of 1 
1 out of 14 Years Active: 2016
Title: The Innovative Mind of Tadasuke Komori: A Breakthrough in Atopic Dermatitis Treatment
Introduction: Tadasuke Komori, an accomplished inventor based in Wakayama, Japan, has made significant contributions to the field of medicine with his pioneering research. His work primarily focuses on the development of innovative therapeutic solutions, especially targeting conditions such as atopic dermatitis. His impressive portfolio includes a notable patent that exemplifies his commitment to improving patient well-being.
Latest Patents: Tadasuke Komori holds a patent for an anti-oncostatin M receptor beta antibody designed for treating atopic dermatitis. This invention is a monoclonal antibody that targets the oncostatin M specific receptor beta subunit. Moreover, it encompasses a hybridoma capable of producing this antibody, along with a medicament that incorporates this innovative solution for treating atopic dermatitis.
Career Highlights: Throughout his career, Tadasuke Komori has collaborated with esteemed institutions such as Wakayama Medical University and SBi Biotech Co., Ltd. His experiences in these organizations have allowed him to push the boundaries of scientific research and develop groundbreaking medical treatments.
Collaborations: Komori has worked alongside notable colleagues in his field, including Yoshihiro Morikawa and Eiji Esashi. Their collaborative efforts have further enhanced the success and impact of his inventions, leading to advancements in medical therapies for challenging health conditions.
Conclusion: Tadasuke Komori stands as a prominent figure in the realm of medical inventions, with his patent for an anti-oncostatin M receptor beta antibody demonstrating his dedication to addressing critical health issues. Through his career, he continues to inspire future innovations that hold promise for effectively treating patients suffering from atopic dermatitis and beyond.